Expanded
Compliance Services

GREENLEAF ANNOUNCES:

Greenleaf has expanded its portfolio of services to include comprehensive on-site compliance assessments, remediation and inspection readiness.

Greenleaf’s expansion includes additional technical experts who can be deployed to support the firm’s robust strategic and technical expertise.

Learn More
News

GREENLEAF HEALTH EXPANDS COMPLIANCE PORTFOLIO TO INCLUDE GOOD CLINICAL PRACTICE (GCP) SERVICES

WASHINGTON, D.C.  – Greenleaf Health, a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces that the firm has expanded its compliance and manufacturing portfolio to include Good …

Read More

News

GREENLEAF HEALTH & TRIO HEALTH PARTNER TO APPLY FDA-LEVEL RIGOR TO GROUNDBREAKING DATA PLATFORM

WASHINGTON, D.C, October 1, 2019— Greenleaf Health, a leading Food and Drug Administration (FDA) regulatory consulting firm, today announced it has entered into an exclusive agreement with Trio Health, a …

Read More

News

GREENLEAF HEALTH EXPANDS SERVICES TO SUPPORT CELL & GENE THERAPY

Karen Midthun, M.D. & John Taylor to Lead Team of Experts WASHINGTON, D.C. – Greenleaf Health, Inc., a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces that …

Read More

News

KAREN MIDTHUN, M.D., FORMER FDA BIOLOGICS CENTER DIRECTOR, JOINS GREENLEAF HEALTH

Firm Announces Dr. Midthun as Principal, Drug and Biological Products WASHINGTON, D.C. – Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug Administration (FDA or agency) regulatory consulting firm, today …

Read More

News

FDA COMPLIANCE EXPERT, KRISTEN GRUMET, JOINS GREENLEAF

Greenleaf Health announces that Kristen Grumet has joined the firm as Senior Vice President, Regulatory Compliance.  The addition of Grumet to Greenleaf’s team of experts further enhances the firm’s expanded …

Read More

News

Greenleaf Expands Quality & Compliance Services

Greenleaf Health today announced the firm has expanded its portfolio of services to include comprehensive on-site compliance assessments, remediation, and inspection readiness.  By expanding Greenleaf’s compliance service portfolio, the firm …

Read More

News

ROBERT J. MEYER, M.D. JOINS GREENLEAF HEALTH

Greenleaf Health announces that Robert (Bob) Meyer, M.D. has joined the firm as Principal, Drug and Biological Products. Dr. Meyer and Dr. John Jenkins, Principal, Drug and Biological Products, will …

Read More